Fig. 1
From: Endophenotypical drift in Huntington’s disease: a 5-year follow-up study
Flowchart used for categorization of participants into the neuropsychiatric vs. the non-neuropsychiatric groups. Psychotropic—meaning use of psychotropic medication in the motor manifest group, 4 participants did not complete the SCL-90-R, 2 received psychotropic medication and therefore classified as having psychiatric symptoms and 2 did not receive psychotropic medication and were clinically evaluated as not having psychiatric symptoms